Great Point Partners LLC Magenta Therapeutics, Inc. Transaction History

Great Point Partners LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.26 - $2.09 $190,145 - $315,399	-150,909 Reduced 12.9%	1,019,091 $1.44 Million
Q3 2021 Nov 15, 2021	BUY	$6.07 - $9.89 $357,456 - $582,412	58,889 Added 5.3%	1,170,000 $8.52 Million
Q2 2021 Aug 16, 2021	BUY	$9.76 - $14.15 $10.8 Million - $15.7 Million	1,111,111 New	1,111,111 $10.9 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.